Therapy of invasive infections due to multidrug-resistant Enterobacteriaceae (MDR-E) is
challenging, and some of the few active drugs are not available in many countries. For …

First variants of the Klebsiella pneumoniae carbapenemase (KPC), KPC-2 and KPC-3, have
encountered a worldwide success, particularly in K. pneumoniae isolates. These beta …

Scope These ESCMID guidelines address the targeted antibiotic treatment of third-
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …

Carbapenem-resistant Enterobacteriaceae (CRE) are major health care-associated
pathogens and responsible for hospital outbreaks worldwide. To prevent a further increase …

ABSTRACT Introduction: Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp.
infections are major causes of morbidity and mortality, especially due to the emergence and …

Carbapenem-resistant Enterobacteriaceae (CRE) are a major global public health concern
and pose a serious threat to immunocompromised hosts, particularly patients with …

Introduction KPC carbapenemase-producing Klebsiella pneumoniae (KPC-KP) has become
a major public health challenge. Accordingly, this study sought to use a systematic review of …

Abstract Background Carbapenem-resistant Klebsiella pneumoniae (CRKP) spread and
infections in patients with haematological malignancies are a serious concern especially in …

This study aimed to describe severe infections with extensively drug-resistant Acinetobacter
baumannii–calcoaceticus complex (XDR-ABC), as well as to investigate risk factors for …

Colistin and polymyxin B are increasingly reintroduced in clinical practice due to the
absence of effective antibiotics for the treatment of emerging infections caused by gram …